🧬 AI Meets Drug Discovery: How Michael Holden, PhD Is Reinventing Protein Engineering with Fabrikagen AI

What if discovering life-saving medicines could take days instead of years?

On this episode of the Bold Inventors Show, J.D. Houvener and Matt Kulseth sit down with Michael Holden, PhD, founder of Fabrikagen AI, to explore how artificial intelligence is transforming the future of biologics, protein engineering, and pharmaceutical discovery. 

After earning his PhD studying protein folding and Alzheimer's disease and leading chemistry teams in biotech, Michael found himself at a career crossroads. Instead of relocating his family once again, he bet on himself—launching Fabrikagen AI to dramatically accelerate antibody discovery using proprietary AI models and laboratory validation.

The conversation explores how AI is reshaping drug development, why proteins are the foundation of biology, the future of pharmaceutical innovation, and how patents help protect breakthrough technologies before they reach the marketplace.

🚀 In This Episode:

🧬 How AI is revolutionizing protein engineering
 💊 Why antibody drugs dominate modern medicine
 ⚡ Cutting drug discovery timelines from years to days
 🖥️ Combining AI models with real laboratory validation
 🧪 The future of biologics and pharmaceutical R&D
 📈 Building a biotech startup after leaving corporate leadership
 📜 Why patents remain essential for AI-powered innovation
 🤝 Using provisional patents while negotiating licensing deals
 🌎 The global race between U.S., Chinese, and European biotech
 💡 Advice for inventors commercializing cutting-edge technology

Whether you're an inventor, scientist, entrepreneur, investor, or simply fascinated by where AI is taking healthcare, this episode offers an exciting glimpse into the next generation of innovation.

🔑 Key Takeaways

✅ AI can dramatically accelerate early-stage drug discovery
 ✅ Protein engineering has applications far beyond pharmaceuticals
 ✅ Combining software with laboratory validation creates a powerful competitive advantage
 ✅ Patents remain critical for protecting AI-enabled inventions
 ✅ Strong industry relationships can accelerate commercialization
 ✅ Innovation often begins by solving problems you've personally experienced
 ✅ The future of medicine will increasingly rely on AI-guided biological design

#BoldInventors, #MichaelHolden, #FabrikagenAI, #ArtificialIntelligence, #Biotech, #DrugDiscovery, #ProteinEngineering, #Biologics, #PatentLaw, #Innovation, #Entrepreneurship, #AIHealthcare, #LifeSciences, #StartupFounder, #Biotechnology, #MachineLearning, #InventorJourney, #Pharmaceuticals, #GoBigGoBold, #BoldPatents